OJJAARA-100mg (Momelotinib Tablet) 100 mg

OJJAARA 100 mg tablets contain momelotinib, a prescription medication for certain blood disorders. It is used to manage symptoms like fatigue and low blood cell counts. This overview covers key details for informational purposes only. Always consult a healthcare provider before use.

Strength

100 mg

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Momelotinib 100 mg tablets are primarily used to treat myelofibrosis, a type of bone marrow disorder. It helps reduce symptoms such as fatigue, weakness, and enlarged spleen. Patients often ask, 'what is momelotinib used for?' to understand its role in managing chronic conditions. This medication supports blood cell production and improves quality of life.

Side Effects

Users of momelotinib 100 mg tablets may experience improved energy levels and reduced discomfort associated with enlarged spleens. Some report better daily functioning due to stabilized blood counts. These effects vary by individual and should be monitored by a healthcare professional.

Precautions & Warnings

Keep momelotinib 100 mg tablets in a cool, dry place away from children and pets. Avoid crushing or splitting tablets unless directed by a doctor. Regular blood tests are recommended to track your body's response. Discuss any pre-existing conditions with your healthcare provider before starting this medication.

Avoid Interactions

Momelotinib 100 mg may interact with other medications, including certain antibiotics and antifungals. Avoid grapefruit products as they can affect how the drug works. Alcohol and herbal supplements may also alter its effectiveness. Always inform your doctor about all medicines and supplements you are taking.

References

Frequently Asked Questions

Momelotinib is used to treat myelofibrosis, a bone marrow disorder causing fatigue and enlarged spleen.

Store in a cool, dry place away from light and moisture. Keep out of reach of children.

Consult your doctor before combining with other drugs, as interactions may occur.

Common effects may include fatigue, dizziness, or changes in blood counts. Report persistent issues to your healthcare provider.

Long-term safety depends on individual health factors. Regular monitoring by a doctor is essential.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.